The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Kennedy Jr., President Trump's pick for health secretary, has falsely linked vaccines to autism and argued people should have ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...